ProShares Ultra NASDAQ Biotechnology
27 hedge funds and large institutions have $16.2M invested in ProShares Ultra NASDAQ Biotechnology in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 16 closing their positions.
Holders
27
Holders Change
-14
Holders Change %
-34.15%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
9
Closed
16
Calls
$6.66M
Puts
$4.96M
Net Calls
+$1.7M
Net Calls Change
+$2.35M